

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | diaphragm development (GO:0060539) | 9.34303869 |
| 2 | arginine catabolic process (GO:0006527) | 9.05970441 |
| 3 | skeletal muscle organ development (GO:0060538) | 8.39690883 |
| 4 | pyrimidine-containing compound salvage (GO:0008655) | 8.24796832 |
| 5 | pyrimidine nucleoside salvage (GO:0043097) | 8.24796832 |
| 6 | cellular protein complex localization (GO:0034629) | 8.17277186 |
| 7 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 7.98053321 |
| 8 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 7.58384848 |
| 9 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 7.35262821 |
| 10 | negative regulation of vascular permeability (GO:0043116) | 7.05752806 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 7.01347278 |
| 12 | arginine metabolic process (GO:0006525) | 6.99681503 |
| 13 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 6.79443542 |
| 14 | UMP biosynthetic process (GO:0006222) | 6.79443542 |
| 15 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 6.79443542 |
| 16 | UMP metabolic process (GO:0046049) | 6.79443542 |
| 17 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 6.78297804 |
| 18 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 6.57136826 |
| 19 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 6.38984262 |
| 20 | response to lipoprotein particle (GO:0055094) | 6.23343610 |
| 21 | exogenous drug catabolic process (GO:0042738) | 5.81650942 |
| 22 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.72563068 |
| 23 | nucleotide salvage (GO:0043173) | 5.72294783 |
| 24 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 5.63908969 |
| 25 | protein complex localization (GO:0031503) | 5.53608072 |
| 26 | negative regulation of potassium ion transport (GO:0043267) | 5.45296441 |
| 27 | positive regulation of receptor biosynthetic process (GO:0010870) | 5.39250963 |
| 28 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 5.35445911 |
| 29 | nucleoside salvage (GO:0043174) | 5.30380029 |
| 30 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.27855192 |
| 31 | regulation of guanylate cyclase activity (GO:0031282) | 5.25954342 |
| 32 | adenine nucleotide transport (GO:0051503) | 5.25831658 |
| 33 | activation of MAPKKK activity (GO:0000185) | 5.21249474 |
| 34 | protein heterotrimerization (GO:0070208) | 5.14150316 |
| 35 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.00147310 |
| 36 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 4.87941317 |
| 37 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 4.86877127 |
| 38 | histone H3-K4 methylation (GO:0051568) | 4.72324491 |
| 39 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.71331193 |
| 40 | negative regulation of granulocyte differentiation (GO:0030853) | 4.68866517 |
| 41 | regulation of stem cell maintenance (GO:2000036) | 4.49668925 |
| 42 | hypotonic response (GO:0006971) | 4.48256080 |
| 43 | regulation of neurotransmitter uptake (GO:0051580) | 4.48027439 |
| 44 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.40756855 |
| 45 | negative regulation of protein kinase B signaling (GO:0051898) | 4.38256623 |
| 46 | nerve growth factor signaling pathway (GO:0038180) | 4.32162499 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.23723497 |
| 48 | purine nucleotide transport (GO:0015865) | 4.21850237 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 4.20625324 |
| 50 | drug catabolic process (GO:0042737) | 4.20462431 |
| 51 | negative regulation of alcohol biosynthetic process (GO:1902931) | 4.18386323 |
| 52 | nitric oxide biosynthetic process (GO:0006809) | 4.13784407 |
| 53 | negative regulation of macrophage differentiation (GO:0045650) | 4.12102669 |
| 54 | ncRNA 3-end processing (GO:0043628) | 4.09478270 |
| 55 | chromatin silencing (GO:0006342) | 4.06586370 |
| 56 | regulation of integrin activation (GO:0033623) | 4.06326191 |
| 57 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.00757212 |
| 58 | purine ribonucleotide transport (GO:0015868) | 3.96461227 |
| 59 | urea cycle (GO:0000050) | 3.96232504 |
| 60 | histone H4-K12 acetylation (GO:0043983) | 3.93127907 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 3.92803900 |
| 62 | CTP metabolic process (GO:0046036) | 3.86079501 |
| 63 | CTP biosynthetic process (GO:0006241) | 3.86079501 |
| 64 | pre-miRNA processing (GO:0031054) | 3.85030538 |
| 65 | regulation of protein deacetylation (GO:0090311) | 3.82489659 |
| 66 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.80636354 |
| 67 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.78783765 |
| 68 | regulation of hippo signaling (GO:0035330) | 3.77777715 |
| 69 | heterochromatin organization (GO:0070828) | 3.77053347 |
| 70 | positive regulation of histone acetylation (GO:0035066) | 3.76222527 |
| 71 | myoblast fusion (GO:0007520) | 3.74301953 |
| 72 | lateral sprouting from an epithelium (GO:0060601) | 3.71762013 |
| 73 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.67462191 |
| 74 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.66671241 |
| 75 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.66138891 |
| 76 | regulation of gene silencing by miRNA (GO:0060964) | 3.66138891 |
| 77 | regulation of gene silencing by RNA (GO:0060966) | 3.66138891 |
| 78 | regulation of cell size (GO:0008361) | 3.62653430 |
| 79 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.60210682 |
| 80 | urea metabolic process (GO:0019627) | 3.58462712 |
| 81 | Rap protein signal transduction (GO:0032486) | 3.57926444 |
| 82 | regulation of oxidative phosphorylation (GO:0002082) | 3.57391955 |
| 83 | response to nerve growth factor (GO:1990089) | 3.52794201 |
| 84 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.52794201 |
| 85 | regulation of mRNA catabolic process (GO:0061013) | 3.50747896 |
| 86 | dosage compensation (GO:0007549) | 3.47117290 |
| 87 | nitric oxide mediated signal transduction (GO:0007263) | 3.42518272 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 3.41985976 |
| 89 | positive regulation of catecholamine secretion (GO:0033605) | 3.41132860 |
| 90 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.40357144 |
| 91 | positive regulation of protein acetylation (GO:1901985) | 3.39150635 |
| 92 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 3.39150635 |
| 93 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.38977406 |
| 94 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.37678803 |
| 95 | neurotransmitter biosynthetic process (GO:0042136) | 3.37671745 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36496270 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36496270 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.36496270 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36496270 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 3.36496270 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36496270 |
| 102 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.35683739 |
| 103 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.32624489 |
| 104 | regulation of cholesterol storage (GO:0010885) | 3.32589871 |
| 105 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.32434642 |
| 106 | negative regulation of interleukin-2 production (GO:0032703) | 3.32082317 |
| 107 | regulation of translational fidelity (GO:0006450) | 3.31516946 |
| 108 | apoptotic process involved in morphogenesis (GO:0060561) | 3.30666412 |
| 109 | regulation of synaptic vesicle transport (GO:1902803) | 3.30131471 |
| 110 | regulation of monocyte differentiation (GO:0045655) | 3.28322545 |
| 111 | inactivation of MAPK activity (GO:0000188) | 3.27263908 |
| 112 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.27016793 |
| 113 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.25690880 |
| 114 | regulation of cholesterol metabolic process (GO:0090181) | 3.25497775 |
| 115 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.23200807 |
| 116 | embryonic process involved in female pregnancy (GO:0060136) | 3.23151055 |
| 117 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.22042588 |
| 118 | pentose-phosphate shunt (GO:0006098) | 3.16046133 |
| 119 | histone H4-K8 acetylation (GO:0043982) | 3.14625506 |
| 120 | histone H4-K5 acetylation (GO:0043981) | 3.14625506 |
| 121 | embryonic placenta development (GO:0001892) | 3.14554513 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 3.09480028 |
| 123 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.08241079 |
| 124 | establishment of apical/basal cell polarity (GO:0035089) | 3.06290159 |
| 125 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.05376794 |
| 126 | regulation of early endosome to late endosome transport (GO:2000641) | 2.92397052 |
| 127 | NADPH regeneration (GO:0006740) | 2.88763673 |
| 128 | determination of adult lifespan (GO:0008340) | 2.87838834 |
| 129 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.87568788 |
| 130 | apoptotic cell clearance (GO:0043277) | 2.85641239 |
| 131 | regulation of cholesterol homeostasis (GO:2000188) | 2.84740018 |
| 132 | maternal placenta development (GO:0001893) | 2.81467780 |
| 133 | RNA stabilization (GO:0043489) | 2.80120147 |
| 134 | mRNA stabilization (GO:0048255) | 2.80120147 |
| 135 | NLS-bearing protein import into nucleus (GO:0006607) | 2.78266988 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.75636055 |
| 137 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.73253632 |
| 138 | negative regulation of glial cell proliferation (GO:0060253) | 2.72681410 |
| 139 | positive regulation of interferon-alpha production (GO:0032727) | 2.70970681 |
| 140 | chromatin assembly (GO:0031497) | 2.67089248 |
| 141 | trophectodermal cell differentiation (GO:0001829) | 2.65824839 |
| 142 | proline biosynthetic process (GO:0006561) | 2.65005942 |
| 143 | lysine metabolic process (GO:0006553) | 2.64397324 |
| 144 | lysine catabolic process (GO:0006554) | 2.64397324 |
| 145 | urate metabolic process (GO:0046415) | 2.64388921 |
| 146 | cellular modified amino acid catabolic process (GO:0042219) | 2.63628424 |
| 147 | nodal signaling pathway (GO:0038092) | 2.63284549 |
| 148 | nuclear pore organization (GO:0006999) | 2.62153402 |
| 149 | protein localization to kinetochore (GO:0034501) | 2.61994421 |
| 150 | positive regulation of histone deacetylation (GO:0031065) | 2.61327822 |
| 151 | establishment of monopolar cell polarity (GO:0061162) | 2.60834963 |
| 152 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.60834963 |
| 153 | vagina development (GO:0060068) | 2.59843950 |
| 154 | proline metabolic process (GO:0006560) | 2.58137544 |
| 155 | female genitalia development (GO:0030540) | 2.54982374 |
| 156 | folic acid metabolic process (GO:0046655) | 2.54426056 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.51756616 |
| 158 | negative regulation of cell size (GO:0045792) | 2.48833789 |
| 159 | apoptotic process involved in development (GO:1902742) | 2.47108172 |
| 160 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.46911661 |
| 161 | valine metabolic process (GO:0006573) | 2.43030562 |
| 162 | anterior/posterior axis specification, embryo (GO:0008595) | 2.43016678 |
| 163 | regulation of podosome assembly (GO:0071801) | 2.42851337 |
| 164 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.42654147 |
| 165 | paraxial mesoderm development (GO:0048339) | 2.42285665 |
| 166 | developmental programmed cell death (GO:0010623) | 2.40955923 |
| 167 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.40411758 |
| 168 | regulation of protein polyubiquitination (GO:1902914) | 2.40275776 |
| 169 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.40119228 |
| 170 | histone H4-K16 acetylation (GO:0043984) | 2.39922946 |
| 171 | regulation of translational termination (GO:0006449) | 2.38477063 |
| 172 | negative regulation of interleukin-12 production (GO:0032695) | 2.37320651 |
| 173 | homocysteine metabolic process (GO:0050667) | 2.37007416 |
| 174 | macrophage activation involved in immune response (GO:0002281) | 2.36642689 |
| 175 | regulation of RNA export from nucleus (GO:0046831) | 2.36216377 |
| 176 | serine family amino acid catabolic process (GO:0009071) | 2.34352898 |
| 177 | negative regulation of viral release from host cell (GO:1902187) | 2.33959740 |
| 178 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.33468123 |
| 179 | response to laminar fluid shear stress (GO:0034616) | 2.31512974 |
| 180 | regulation of glial cell proliferation (GO:0060251) | 2.26382614 |
| 181 | glucose catabolic process (GO:0006007) | 2.25424989 |
| 182 | positive regulation of interferon-beta production (GO:0032728) | 2.25341452 |
| 183 | intestinal epithelial cell development (GO:0060576) | 2.25111503 |
| 184 | mitochondrial DNA metabolic process (GO:0032042) | 2.24441053 |
| 185 | regulation of protein homooligomerization (GO:0032462) | 2.23777222 |
| 186 | negative regulation of histone methylation (GO:0031061) | 2.23672439 |
| 187 | tricarboxylic acid metabolic process (GO:0072350) | 2.23450112 |
| 188 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.23230607 |
| 189 | response to UV-C (GO:0010225) | 2.22526059 |
| 190 | regulation of gene silencing (GO:0060968) | 2.21320215 |
| 191 | B cell mediated immunity (GO:0019724) | 2.21065436 |
| 192 | positive regulation of protein homooligomerization (GO:0032464) | 2.20566444 |
| 193 | regulation of sister chromatid cohesion (GO:0007063) | 2.20553582 |
| 194 | immunoglobulin mediated immune response (GO:0016064) | 2.19889797 |
| 195 | cellular response to virus (GO:0098586) | 2.19447153 |
| 196 | positive regulation of cell size (GO:0045793) | 10.3706993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.62214912 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 4.10681158 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.63118377 |
| 4 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.89521721 |
| 5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.89492235 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.89492235 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.89492235 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86999129 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79695144 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70262921 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.66663032 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62467900 |
| 13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.60469095 |
| 14 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.58042940 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.54475838 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.50063391 |
| 17 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.36278524 |
| 18 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.33178729 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30916993 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.26848366 |
| 21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.25467705 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12072140 |
| 23 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.10724424 |
| 24 | * SMC4_20622854_ChIP-Seq_HELA_Human | 2.10397765 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09269223 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.06723159 |
| 27 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.03063372 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.01713307 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01700318 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 10.4873493 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.99387106 |
| 32 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.95221010 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.94071419 |
| 34 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.81995038 |
| 35 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.81632916 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.81400075 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79692660 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79675656 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78144101 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75276189 |
| 41 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.74466661 |
| 42 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.72242081 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71770502 |
| 44 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71476757 |
| 45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69713775 |
| 46 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.69026051 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67272853 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67019897 |
| 49 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.64256287 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62759389 |
| 51 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.61841398 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58646154 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57906021 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57810826 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52088612 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51888920 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.50235200 |
| 58 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50041689 |
| 59 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.49190983 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49186919 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46380965 |
| 62 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.44599881 |
| 63 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44013546 |
| 64 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.38343065 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35951647 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34815966 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32600230 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32031659 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31072806 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 1.29293351 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27626069 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26946277 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25118461 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24402977 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23241691 |
| 76 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.23189968 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22703845 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22370875 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21183908 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20626075 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20394036 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20276700 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19812874 |
| 84 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19802276 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18396073 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17023070 |
| 87 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16098739 |
| 88 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15099246 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14846415 |
| 90 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14752473 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13400923 |
| 92 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.13037156 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12377857 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11733341 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11014676 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10745881 |
| 97 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.10642470 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10604574 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10564366 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10564366 |
| 101 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09446257 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08871714 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08577356 |
| 104 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.08437387 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08349614 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08176102 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07407427 |
| 108 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.07050810 |
| 109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06757534 |
| 110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06596029 |
| 111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06167191 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04717369 |
| 113 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04710414 |
| 114 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.04354726 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04329356 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04144301 |
| 117 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04137950 |
| 118 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.04097078 |
| 119 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03848347 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03548225 |
| 121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03511271 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03477265 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03294860 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02858337 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02841804 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02244444 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02126402 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01988954 |
| 129 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.00040077 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99537184 |
| 131 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99419040 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99217315 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98699780 |
| 134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97944094 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97439539 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96956830 |
| 137 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96923868 |
| 138 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95133521 |
| 139 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94881412 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94364143 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94125613 |
| 142 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93903636 |
| 143 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.93870507 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93717082 |
| 145 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92684917 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92642876 |
| 147 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.92441863 |
| 148 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.90130495 |
| 149 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89929075 |
| 150 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88631906 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88490231 |
| 152 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88376357 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88069971 |
| 154 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87584429 |
| 155 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87343498 |
| 156 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84874868 |
| 157 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84070349 |
| 158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83958201 |
| 159 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83911165 |
| 160 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.83818564 |
| 161 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82511903 |
| 162 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82267810 |
| 163 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.80924444 |
| 164 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.79570237 |
| 165 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78793594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 7.87728296 |
| 2 | MP0003646_muscle_fatigue | 7.24033687 |
| 3 | MP0002234_abnormal_pharynx_morphology | 5.28747960 |
| 4 | MP0004233_abnormal_muscle_weight | 5.00775343 |
| 5 | MP0010368_abnormal_lymphatic_system | 4.68087462 |
| 6 | MP0004043_abnormal_pH_regulation | 3.96768177 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.74521447 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 3.53350881 |
| 9 | MP0005360_urolithiasis | 3.32106206 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.76072411 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.71083481 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.61952910 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.59961806 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.51755631 |
| 15 | MP0009278_abnormal_bone_marrow | 2.41305049 |
| 16 | MP0008057_abnormal_DNA_replication | 2.40967817 |
| 17 | MP0003045_fibrosis | 2.40277600 |
| 18 | MP0009840_abnormal_foam_cell | 2.31109982 |
| 19 | MP0001849_ear_inflammation | 2.31083280 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.28166019 |
| 21 | MP0003303_peritoneal_inflammation | 2.25650813 |
| 22 | MP0003283_abnormal_digestive_organ | 2.25638127 |
| 23 | MP0008961_abnormal_basal_metabolism | 2.23422792 |
| 24 | MP0000467_abnormal_esophagus_morphology | 2.03328162 |
| 25 | MP0004858_abnormal_nervous_system | 2.01076621 |
| 26 | MP0010307_abnormal_tumor_latency | 1.97912725 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.90527260 |
| 28 | MP0003890_abnormal_embryonic-extraembry | 1.83439480 |
| 29 | MP0006082_CNS_inflammation | 1.75343525 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.74426989 |
| 31 | MP0000371_diluted_coat_color | 1.71172575 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.70956614 |
| 33 | MP0002009_preneoplasia | 1.65660015 |
| 34 | MP0005365_abnormal_bile_salt | 1.64537344 |
| 35 | MP0000490_abnormal_crypts_of | 1.64144538 |
| 36 | MP0003436_decreased_susceptibility_to | 1.63891205 |
| 37 | MP0003718_maternal_effect | 1.61063138 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.57782757 |
| 39 | MP0006138_congestive_heart_failure | 1.53781403 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.53293004 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.52857449 |
| 42 | MP0002086_abnormal_extraembryonic_tissu | 1.50933725 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.49681657 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.49662031 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.49653239 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.49382616 |
| 47 | MP0001664_abnormal_digestion | 1.47849056 |
| 48 | MP0000767_abnormal_smooth_muscle | 1.43949773 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.41661519 |
| 50 | MP0005380_embryogenesis_phenotype | 1.41661519 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.40128151 |
| 52 | MP0002233_abnormal_nose_morphology | 1.37801026 |
| 53 | MP0000350_abnormal_cell_proliferation | 1.34483637 |
| 54 | MP0001730_embryonic_growth_arrest | 1.33324236 |
| 55 | MP0003984_embryonic_growth_retardation | 1.32812790 |
| 56 | MP0002084_abnormal_developmental_patter | 1.31962854 |
| 57 | MP0002088_abnormal_embryonic_growth/wei | 1.31887721 |
| 58 | MP0003448_altered_tumor_morphology | 1.30778667 |
| 59 | MP0001919_abnormal_reproductive_system | 1.26861051 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.26776360 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.25956679 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.25496521 |
| 63 | MP0003111_abnormal_nucleus_morphology | 1.24442467 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 1.21295750 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 1.18624610 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.18526735 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.18526735 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 1.18326894 |
| 69 | MP0000609_abnormal_liver_physiology | 1.17503902 |
| 70 | MP0003252_abnormal_bile_duct | 1.16321175 |
| 71 | MP0004133_heterotaxia | 1.16274167 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.16174940 |
| 73 | MP0002085_abnormal_embryonic_tissue | 1.15235620 |
| 74 | MP0003077_abnormal_cell_cycle | 1.11883041 |
| 75 | MP0008260_abnormal_autophagy | 1.11222289 |
| 76 | MP0004197_abnormal_fetal_growth/weight/ | 1.10939900 |
| 77 | MP0005083_abnormal_biliary_tract | 1.10509827 |
| 78 | MP0008775_abnormal_heart_ventricle | 1.10273382 |
| 79 | MP0008872_abnormal_physiological_respon | 1.10041877 |
| 80 | MP0005332_abnormal_amino_acid | 1.08503220 |
| 81 | MP0004484_altered_response_of | 1.08214757 |
| 82 | MP0002127_abnormal_cardiovascular_syste | 1.07396328 |
| 83 | MP0000470_abnormal_stomach_morphology | 1.03782944 |
| 84 | MP0001697_abnormal_embryo_size | 1.03731276 |
| 85 | MP0003123_paternal_imprinting | 1.03459122 |
| 86 | MP0001293_anophthalmia | 1.02474226 |
| 87 | MP0010329_abnormal_lipoprotein_level | 1.01786587 |
| 88 | MP0005023_abnormal_wound_healing | 1.01365846 |
| 89 | MP0003119_abnormal_digestive_system | 1.00831371 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 1.00772199 |
| 91 | MP0005197_abnormal_uvea_morphology | 0.99976358 |
| 92 | MP0002254_reproductive_system_inflammat | 0.99299320 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.97028494 |
| 94 | MP0000685_abnormal_immune_system | 0.96384188 |
| 95 | MP0005670_abnormal_white_adipose | 0.95246655 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.94084968 |
| 97 | MP0004947_skin_inflammation | 0.93893251 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.92781001 |
| 99 | MP0002116_abnormal_craniofacial_bone | 0.92502009 |
| 100 | MP0002092_abnormal_eye_morphology | 0.92216979 |
| 101 | MP0001881_abnormal_mammary_gland | 0.91971827 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.91802138 |
| 103 | MP0004883_abnormal_blood_vessel | 0.91424448 |
| 104 | MP0000598_abnormal_liver_morphology | 0.91203753 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.90848183 |
| 106 | MP0002080_prenatal_lethality | 0.90653660 |
| 107 | MP0003091_abnormal_cell_migration | 0.90473314 |
| 108 | MP0009115_abnormal_fat_cell | 0.90257480 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.88604381 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.85718280 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.85044295 |
| 112 | MP0001764_abnormal_homeostasis | 0.84425232 |
| 113 | MP0002113_abnormal_skeleton_development | 0.84340959 |
| 114 | MP0002109_abnormal_limb_morphology | 0.82738438 |
| 115 | MP0000432_abnormal_head_morphology | 0.80309451 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.78874621 |
| 117 | MP0002970_abnormal_white_adipose | 0.78253234 |
| 118 | MP0009764_decreased_sensitivity_to | 0.78220518 |
| 119 | MP0009053_abnormal_anal_canal | 0.77567523 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.77541432 |
| 121 | MP0001835_abnormal_antigen_presentation | 0.77469431 |
| 122 | MP0000733_abnormal_muscle_development | 0.77062112 |
| 123 | MP0001915_intracranial_hemorrhage | 0.76775243 |
| 124 | MP0005025_abnormal_response_to | 0.76415417 |
| 125 | MP0000313_abnormal_cell_death | 0.74509098 |
| 126 | MP0004130_abnormal_muscle_cell | 0.73378977 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.73060600 |
| 128 | MP0002019_abnormal_tumor_incidence | 0.73019119 |
| 129 | MP0008770_decreased_survivor_rate | 0.72219428 |
| 130 | MP0005387_immune_system_phenotype | 0.71390036 |
| 131 | MP0001790_abnormal_immune_system | 0.71390036 |
| 132 | MP0000163_abnormal_cartilage_morphology | 0.71354936 |
| 133 | MP0000858_altered_metastatic_potential | 0.70810306 |
| 134 | MP0005166_decreased_susceptibility_to | 0.69316017 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.68757584 |
| 136 | MP0003075_altered_response_to | 0.68432115 |
| 137 | MP0010094_abnormal_chromosome_stability | 0.67281557 |
| 138 | MP0003942_abnormal_urinary_system | 0.67041160 |
| 139 | MP0005266_abnormal_metabolism | 0.66807633 |
| 140 | MP0002405_respiratory_system_inflammati | 0.66770268 |
| 141 | MP0009672_abnormal_birth_weight | 0.65461600 |
| 142 | MP0003279_aneurysm | 0.65261468 |
| 143 | MP0000428_abnormal_craniofacial_morphol | 0.63742789 |
| 144 | MP0003937_abnormal_limbs/digits/tail_de | 0.62647659 |
| 145 | MP0005394_taste/olfaction_phenotype | 0.62315515 |
| 146 | MP0005499_abnormal_olfactory_system | 0.62315515 |
| 147 | MP0003763_abnormal_thymus_physiology | 0.61791205 |
| 148 | MP0005409_darkened_coat_color | 0.59436415 |
| 149 | MP0000955_abnormal_spinal_cord | 0.58060499 |
| 150 | MP0001663_abnormal_digestive_system | 0.56067268 |
| 151 | MP0008874_decreased_physiological_sensi | 0.54771978 |
| 152 | MP0000383_abnormal_hair_follicle | 0.53159110 |
| 153 | MP0004811_abnormal_neuron_physiology | 0.52837402 |
| 154 | MP0002932_abnormal_joint_morphology | 0.52338220 |
| 155 | MP0003633_abnormal_nervous_system | 0.52218210 |
| 156 | MP0002168_other_aberrant_phenotype | 0.51644337 |
| 157 | MP0003828_pulmonary_edema | 0.50351082 |
| 158 | MP0001756_abnormal_urination | 0.47712670 |
| 159 | MP0003631_nervous_system_phenotype | 0.46952320 |
| 160 | MP0002115_abnormal_skeleton_extremities | 0.43067383 |
| 161 | MP0001784_abnormal_fluid_regulation | 0.42190040 |
| 162 | MP0000750_abnormal_muscle_regeneration | 0.41739197 |
| 163 | MP0010630_abnormal_cardiac_muscle | 0.37524266 |
| 164 | MP0005381_digestive/alimentary_phenotyp | 0.37520159 |
| 165 | MP0002128_abnormal_blood_circulation | 0.37394469 |
| 166 | MP0005390_skeleton_phenotype | 0.37252504 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.36213106 |
| 168 | MP0000534_abnormal_ureter_morphology | 0.33865645 |
| 169 | MP0001614_abnormal_blood_vessel | 0.33858255 |
| 170 | MP0002896_abnormal_bone_mineralization | 0.33359433 |
| 171 | MP0002249_abnormal_larynx_morphology | 0.32386678 |
| 172 | MP0000631_abnormal_neuroendocrine_gland | 0.32347935 |
| 173 | MP0001873_stomach_inflammation | 0.31881009 |
| 174 | MP0008058_abnormal_DNA_repair | 0.31041682 |
| 175 | MP0005389_reproductive_system_phenotype | 0.30348927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sparse lateral eyebrow (HP:0005338) | 8.31417906 |
| 2 | Lip pit (HP:0100267) | 8.28819298 |
| 3 | Anal stenosis (HP:0002025) | 7.57741555 |
| 4 | Abnormality of the fingertips (HP:0001211) | 6.77942593 |
| 5 | Depressed nasal tip (HP:0000437) | 6.33509418 |
| 6 | Short 5th finger (HP:0009237) | 5.84232201 |
| 7 | Ureteral stenosis (HP:0000071) | 5.63114557 |
| 8 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 5.40956266 |
| 9 | Ureteral obstruction (HP:0006000) | 5.14163664 |
| 10 | Lower limb hyperreflexia (HP:0002395) | 4.59369129 |
| 11 | Popliteal pterygium (HP:0009756) | 4.45170116 |
| 12 | Long palpebral fissure (HP:0000637) | 4.25612776 |
| 13 | Vertebral hypoplasia (HP:0008417) | 3.97325134 |
| 14 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.97325134 |
| 15 | Ectopic kidney (HP:0000086) | 3.73717423 |
| 16 | Ependymoma (HP:0002888) | 3.71387837 |
| 17 | Preauricular pit (HP:0004467) | 3.66207956 |
| 18 | Periauricular skin pits (HP:0100277) | 3.66207956 |
| 19 | Natal tooth (HP:0000695) | 3.50699191 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.46806099 |
| 21 | Posterior subcapsular cataract (HP:0007787) | 3.37956255 |
| 22 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.20477923 |
| 23 | Hand muscle atrophy (HP:0009130) | 3.16348951 |
| 24 | Neonatal short-limb short stature (HP:0008921) | 3.15038834 |
| 25 | Mask-like facies (HP:0000298) | 3.12562432 |
| 26 | Astrocytoma (HP:0009592) | 3.04838382 |
| 27 | Abnormality of the astrocytes (HP:0100707) | 3.04838382 |
| 28 | Abnormality of the periventricular white matter (HP:0002518) | 2.95849411 |
| 29 | Ectropion (HP:0000656) | 2.92265477 |
| 30 | Congenital hip dislocation (HP:0001374) | 2.89301762 |
| 31 | Self-mutilation (HP:0000742) | 2.85580051 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.81182250 |
| 33 | Trismus (HP:0000211) | 2.73057105 |
| 34 | Facial cleft (HP:0002006) | 2.72808277 |
| 35 | Neonatal death (HP:0003811) | 2.72719542 |
| 36 | Spastic diplegia (HP:0001264) | 2.71914627 |
| 37 | Obstructive sleep apnea (HP:0002870) | 2.69818701 |
| 38 | Broad thumb (HP:0011304) | 2.66874030 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65108001 |
| 40 | Upper motor neuron abnormality (HP:0002127) | 2.60629668 |
| 41 | Ulnar bowing (HP:0003031) | 2.59672997 |
| 42 | Aplasia involving bones of the extremities (HP:0009825) | 2.58368668 |
| 43 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.58368668 |
| 44 | Aplasia of the phalanges of the hand (HP:0009802) | 2.58368668 |
| 45 | Hyperacusis (HP:0010780) | 2.58199921 |
| 46 | Narrow palate (HP:0000189) | 2.56096978 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.55337905 |
| 48 | Upper limb amyotrophy (HP:0009129) | 2.55337905 |
| 49 | Progressive neurologic deterioration (HP:0002344) | 2.54419457 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53622304 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53622304 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53622304 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.52411883 |
| 54 | Metaphyseal cupping (HP:0003021) | 2.50008758 |
| 55 | Pheochromocytoma (HP:0002666) | 2.49870463 |
| 56 | Fatigue (HP:0012378) | 2.48706841 |
| 57 | Short humerus (HP:0005792) | 2.43426469 |
| 58 | Rib fusion (HP:0000902) | 2.42585902 |
| 59 | Broad hallux (HP:0010055) | 2.42258958 |
| 60 | Pustule (HP:0200039) | 2.41355134 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.39975966 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39975966 |
| 63 | Coarctation of aorta (HP:0001680) | 2.38348704 |
| 64 | Hyperglycinuria (HP:0003108) | 2.37657367 |
| 65 | Asymmetry of the thorax (HP:0001555) | 2.34564846 |
| 66 | Cortical dysplasia (HP:0002539) | 2.34019984 |
| 67 | Pseudobulbar signs (HP:0002200) | 2.32850731 |
| 68 | Skin pits (HP:0100276) | 2.31071733 |
| 69 | Turricephaly (HP:0000262) | 2.30256404 |
| 70 | Annular pancreas (HP:0001734) | 2.28259919 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.27514101 |
| 72 | Systemic lupus erythematosus (HP:0002725) | 2.27139292 |
| 73 | Frequent falls (HP:0002359) | 2.26997349 |
| 74 | Pterygium (HP:0001059) | 2.26881255 |
| 75 | Gout (HP:0001997) | 2.26860122 |
| 76 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.26164766 |
| 77 | Wide intermamillary distance (HP:0006610) | 2.24991956 |
| 78 | Recurrent otitis media (HP:0000403) | 2.23359797 |
| 79 | Multiple enchondromatosis (HP:0005701) | 2.23146894 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22374181 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22374181 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22374181 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.21811408 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.21811408 |
| 85 | Absent eyebrow (HP:0002223) | 2.21340408 |
| 86 | Atonic seizures (HP:0010819) | 2.20767213 |
| 87 | Preaxial foot polydactyly (HP:0001841) | 2.19246740 |
| 88 | Myocardial infarction (HP:0001658) | 2.18311000 |
| 89 | Heterotopia (HP:0002282) | 2.16765960 |
| 90 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.12523056 |
| 91 | Absent eyelashes (HP:0000561) | 2.12345231 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.08982711 |
| 93 | Esophageal varix (HP:0002040) | 2.07262243 |
| 94 | Abnormality of cochlea (HP:0000375) | 2.05364580 |
| 95 | Neoplasm of striated muscle (HP:0009728) | 2.04882348 |
| 96 | Eczematoid dermatitis (HP:0000976) | 2.04857999 |
| 97 | Lymphangioma (HP:0100764) | 2.03017302 |
| 98 | Glioma (HP:0009733) | 2.01635407 |
| 99 | Macroorchidism (HP:0000053) | 2.01426221 |
| 100 | Advanced eruption of teeth (HP:0006288) | 2.01425932 |
| 101 | Renal duplication (HP:0000075) | 2.01143654 |
| 102 | Broad phalanges of the hand (HP:0009768) | 2.01139593 |
| 103 | Anal atresia (HP:0002023) | 2.01034244 |
| 104 | Bladder neoplasm (HP:0009725) | 2.00557074 |
| 105 | Bladder carcinoma (HP:0002862) | 2.00557074 |
| 106 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.00512610 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 2.00147943 |
| 108 | Intestinal fistula (HP:0100819) | 1.98542226 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.98351822 |
| 110 | Subcapsular cataract (HP:0000523) | 1.97339445 |
| 111 | Abnormal number of incisors (HP:0011064) | 1.96531765 |
| 112 | Urethral obstruction (HP:0000796) | 1.96227237 |
| 113 | Large earlobe (HP:0009748) | 1.96078690 |
| 114 | Delayed puberty (HP:0000823) | 1.95967842 |
| 115 | Fibular aplasia (HP:0002990) | 1.94606502 |
| 116 | Broad toe (HP:0001837) | 1.94056609 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.93995553 |
| 118 | Precocious puberty (HP:0000826) | 1.93109233 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 1.92377103 |
| 120 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92377103 |
| 121 | Rhabdomyosarcoma (HP:0002859) | 1.92253130 |
| 122 | Polycythemia (HP:0001901) | 1.92194359 |
| 123 | Shawl scrotum (HP:0000049) | 1.92125474 |
| 124 | Elfin facies (HP:0004428) | 1.91724845 |
| 125 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.91439500 |
| 126 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90549560 |
| 127 | Spinal muscular atrophy (HP:0007269) | 1.88008625 |
| 128 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.87970862 |
| 129 | Axonal loss (HP:0003447) | 1.87934914 |
| 130 | Generalized aminoaciduria (HP:0002909) | 1.87347327 |
| 131 | Broad finger (HP:0001500) | 1.86852745 |
| 132 | Spastic tetraparesis (HP:0001285) | 1.85867732 |
| 133 | Mild short stature (HP:0003502) | 1.85711751 |
| 134 | Abnormality of the motor neurons (HP:0002450) | 1.85566694 |
| 135 | Abnormal neuron morphology (HP:0012757) | 1.85566694 |
| 136 | Non-midline cleft lip (HP:0100335) | 1.84273740 |
| 137 | Tinnitus (HP:0000360) | 1.82058361 |
| 138 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.81922142 |
| 139 | Pathologic fracture (HP:0002756) | 1.80213198 |
| 140 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.79867221 |
| 141 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79563630 |
| 142 | Disinhibition (HP:0000734) | 1.79089015 |
| 143 | Vertebral clefting (HP:0008428) | 1.79017153 |
| 144 | Absent hand (HP:0004050) | 1.78358440 |
| 145 | Leiomyosarcoma (HP:0100243) | 1.78174009 |
| 146 | Uterine leiomyosarcoma (HP:0002891) | 1.78174009 |
| 147 | Vaginal fistula (HP:0004320) | 1.76710929 |
| 148 | Resting tremor (HP:0002322) | 1.76570098 |
| 149 | Hypoplastic scapulae (HP:0000882) | 1.76002933 |
| 150 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.76002933 |
| 151 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75441383 |
| 152 | Gastrointestinal carcinoma (HP:0002672) | 1.74121868 |
| 153 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.74121868 |
| 154 | Selective tooth agenesis (HP:0001592) | 1.73936213 |
| 155 | Renal cell carcinoma (HP:0005584) | 1.73002710 |
| 156 | Blue sclerae (HP:0000592) | 1.72913816 |
| 157 | Abnormality of the Achilles tendon (HP:0005109) | 1.72195507 |
| 158 | Cerebral hemorrhage (HP:0001342) | 1.71750066 |
| 159 | Neoplasm of the oral cavity (HP:0100649) | 1.71482056 |
| 160 | Broad phalanx (HP:0006009) | 1.71394879 |
| 161 | Agnosia (HP:0010524) | 1.70263860 |
| 162 | Dysmetric saccades (HP:0000641) | 1.70194750 |
| 163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70059322 |
| 164 | Disproportionate tall stature (HP:0001519) | 1.69159622 |
| 165 | Thoracic kyphosis (HP:0002942) | 1.68814078 |
| 166 | Genu recurvatum (HP:0002816) | 1.68713265 |
| 167 | Visceral angiomatosis (HP:0100761) | 1.67885297 |
| 168 | Rectovaginal fistula (HP:0000143) | 1.66987947 |
| 169 | Rectal fistula (HP:0100590) | 1.66987947 |
| 170 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.65176056 |
| 171 | Increased CSF protein (HP:0002922) | 1.64283308 |
| 172 | Apathy (HP:0000741) | 1.63790897 |
| 173 | Peripheral demyelination (HP:0011096) | 1.62053983 |
| 174 | Nephritis (HP:0000123) | 1.61860059 |
| 175 | Recurrent abscess formation (HP:0002722) | 1.60400420 |
| 176 | Abnormality of macrophages (HP:0004311) | 1.58862473 |
| 177 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.58664378 |
| 178 | Diminished motivation (HP:0000745) | 1.58660886 |
| 179 | Renovascular hypertension (HP:0100817) | 1.58521804 |
| 180 | Achilles tendon contracture (HP:0001771) | 1.57944506 |
| 181 | Vacuolated lymphocytes (HP:0001922) | 1.57265823 |
| 182 | Gingivitis (HP:0000230) | 1.55906925 |
| 183 | Cheilitis (HP:0100825) | 1.55730474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 8.46423853 |
| 2 | CDK12 | 5.48828069 |
| 3 | WNK4 | 5.10851454 |
| 4 | STK39 | 4.97159696 |
| 5 | CCNB1 | 4.81786414 |
| 6 | MAP3K3 | 4.10746831 |
| 7 | MAP3K2 | 4.06972692 |
| 8 | ERN1 | 3.71192900 |
| 9 | PINK1 | 3.65157940 |
| 10 | TRIB3 | 3.19651148 |
| 11 | ICK | 2.82761457 |
| 12 | ILK | 2.56642452 |
| 13 | MAP3K10 | 2.51985579 |
| 14 | PKN2 | 2.35201422 |
| 15 | TYRO3 | 2.33267207 |
| 16 | WNK1 | 2.11274373 |
| 17 | MAP3K9 | 2.10524730 |
| 18 | EEF2K | 2.09747616 |
| 19 | MATK | 2.07605025 |
| 20 | DDR2 | 2.03301139 |
| 21 | BMX | 2.02019112 |
| 22 | PDGFRA | 2.00015571 |
| 23 | CAMK1D | 1.78728061 |
| 24 | RIPK1 | 1.73508280 |
| 25 | CAMK1 | 1.65466739 |
| 26 | NEK1 | 1.65430146 |
| 27 | CAMK4 | 1.65286045 |
| 28 | FGFR4 | 1.58707294 |
| 29 | PAK4 | 1.56960824 |
| 30 | RPS6KC1 | 1.54047726 |
| 31 | RPS6KL1 | 1.54047726 |
| 32 | NEK2 | 1.53174886 |
| 33 | ZAK | 1.48755770 |
| 34 | LATS2 | 1.46300278 |
| 35 | LATS1 | 1.45352951 |
| 36 | RPS6KA6 | 1.42915068 |
| 37 | CSK | 1.42120136 |
| 38 | GRK6 | 1.41963612 |
| 39 | SIK1 | 1.32171141 |
| 40 | MTOR | 1.30888707 |
| 41 | SIK3 | 1.27418567 |
| 42 | PTK6 | 1.24818731 |
| 43 | NTRK2 | 1.24575434 |
| 44 | TRPM7 | 1.21835332 |
| 45 | ALK | 1.21806946 |
| 46 | TAOK2 | 1.17672254 |
| 47 | PRKCQ | 1.17626295 |
| 48 | CDK7 | 1.17420015 |
| 49 | SIK2 | 1.11557736 |
| 50 | FGR | 1.08155028 |
| 51 | TYK2 | 1.08037778 |
| 52 | EPHA2 | 1.06246974 |
| 53 | CSF1R | 1.04869561 |
| 54 | PRPF4B | 1.04436285 |
| 55 | CAMK1G | 0.99822822 |
| 56 | CDK4 | 0.98512696 |
| 57 | CDK6 | 0.97365767 |
| 58 | KSR1 | 0.97003664 |
| 59 | MAP3K6 | 0.96724540 |
| 60 | STK10 | 0.96618105 |
| 61 | TTK | 0.95394021 |
| 62 | SCYL2 | 0.94895013 |
| 63 | RPS6KA2 | 0.92430292 |
| 64 | MAPKAPK5 | 0.91260003 |
| 65 | IRAK3 | 0.91227496 |
| 66 | BLK | 0.88976648 |
| 67 | TGFBR2 | 0.88162621 |
| 68 | CDC7 | 0.87430427 |
| 69 | MAP3K11 | 0.83873474 |
| 70 | EPHB2 | 0.82765853 |
| 71 | PAK6 | 0.82656678 |
| 72 | FGFR3 | 0.82540662 |
| 73 | PIM1 | 0.81817903 |
| 74 | STK38 | 0.79750144 |
| 75 | PDGFRB | 0.79484276 |
| 76 | STK3 | 0.77465867 |
| 77 | MINK1 | 0.77399607 |
| 78 | MAP4K1 | 0.75098155 |
| 79 | DAPK2 | 0.72720453 |
| 80 | UHMK1 | 0.71942508 |
| 81 | BRD4 | 0.71826266 |
| 82 | CDK9 | 0.68925337 |
| 83 | MAPKAPK3 | 0.68148414 |
| 84 | TBK1 | 0.67250671 |
| 85 | FLT3 | 0.67051918 |
| 86 | CHEK2 | 0.66015019 |
| 87 | BCKDK | 0.64922557 |
| 88 | TNK2 | 0.64760412 |
| 89 | TTN | 0.63771380 |
| 90 | JAK2 | 0.62986420 |
| 91 | KSR2 | 0.62836343 |
| 92 | NEK9 | 0.61336526 |
| 93 | PTK2 | 0.59995864 |
| 94 | MAPK11 | 0.59983254 |
| 95 | DAPK1 | 0.59592216 |
| 96 | CAMKK1 | 0.59141452 |
| 97 | GSK3A | 0.58903344 |
| 98 | AKT2 | 0.57288274 |
| 99 | CAMKK2 | 0.56914665 |
| 100 | DYRK1B | 0.56395025 |
| 101 | STK38L | 0.55731689 |
| 102 | SRPK1 | 0.55194839 |
| 103 | MAP3K7 | 0.55164674 |
| 104 | LRRK2 | 0.54910499 |
| 105 | EGFR | 0.54145429 |
| 106 | MAP3K8 | 0.54023605 |
| 107 | HCK | 0.53895382 |
| 108 | EPHB1 | 0.52338771 |
| 109 | TLK1 | 0.51981207 |
| 110 | RPS6KB2 | 0.50694370 |
| 111 | JAK3 | 0.49623851 |
| 112 | KIT | 0.49147141 |
| 113 | PRKAA1 | 0.48982552 |
| 114 | STK4 | 0.48713291 |
| 115 | TAOK1 | 0.47860312 |
| 116 | ZAP70 | 0.47732594 |
| 117 | PAK2 | 0.47334678 |
| 118 | JAK1 | 0.47204820 |
| 119 | RET | 0.46259658 |
| 120 | CHUK | 0.44844209 |
| 121 | CDK2 | 0.43942506 |
| 122 | MAPK12 | 0.41191042 |
| 123 | ACVR1B | 0.40977560 |
| 124 | DYRK3 | 0.40954309 |
| 125 | WNK3 | 0.40849481 |
| 126 | MET | 0.40267199 |
| 127 | MAP2K2 | 0.39422025 |
| 128 | DMPK | 0.38685826 |
| 129 | TESK2 | 0.38279711 |
| 130 | RPS6KA1 | 0.37346317 |
| 131 | CHEK1 | 0.36352457 |
| 132 | PNCK | 0.36055868 |
| 133 | PRKG2 | 0.35549473 |
| 134 | ATR | 0.35353709 |
| 135 | MELK | 0.29467355 |
| 136 | PASK | 0.26305924 |
| 137 | MAPK13 | 0.25318320 |
| 138 | MAP3K5 | 0.24373330 |
| 139 | YES1 | 0.23679592 |
| 140 | PRKCD | 0.15880769 |
| 141 | PRKCZ | 0.14817954 |
| 142 | RPS6KB1 | 0.14671701 |
| 143 | IRAK2 | 0.14338800 |
| 144 | MAPK9 | 0.13636658 |
| 145 | EIF2AK2 | 0.13399098 |
| 146 | PDPK1 | 0.12046908 |
| 147 | CSNK1G3 | 0.11669639 |
| 148 | TNIK | 0.11481481 |
| 149 | IRAK4 | 0.10043246 |
| 150 | SGK2 | 0.09496808 |
| 151 | PRKACG | 0.07598056 |
| 152 | MAPK10 | 0.06258252 |
| 153 | RIPK4 | 0.06164314 |
| 154 | SGK3 | 0.05227419 |
| 155 | CSNK1A1L | 0.03929013 |
| 156 | SRC | 0.03816735 |
| 157 | PDK1 | 0.03274763 |
| 158 | MAP2K1 | 0.02646677 |
| 159 | MAP2K3 | 0.01888383 |
| 160 | PRKCA | 0.01796353 |
| 161 | PRKD3 | 0.01363569 |
| 162 | MAPKAPK2 | -0.0251709 |
| 163 | SGK494 | -0.0229927 |
| 164 | SGK223 | -0.0229927 |
| 165 | NTRK1 | -0.0226520 |
| 166 | SMG1 | -0.0111957 |
| 167 | ROCK1 | -0.0089049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.93979184 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23681759 |
| 3 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.88912993 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.88538535 |
| 5 | Lysine degradation_Homo sapiens_hsa00310 | 1.88340264 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87346120 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83657403 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82756659 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78916517 |
| 10 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.70872813 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.67595620 |
| 12 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.67589744 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67075470 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.66837553 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.65293245 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64954115 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64900547 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.56199926 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55288041 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.53040059 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.53020315 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47811237 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.44724258 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42128569 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.37303594 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.33766014 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33128390 |
| 28 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.31290483 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31223607 |
| 30 | Endocytosis_Homo sapiens_hsa04144 | 1.30264460 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.30048585 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.29852601 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.28781604 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25841318 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24873961 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24319325 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23020408 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22139933 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21652471 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21489518 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20756710 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18591384 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.18319670 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15261929 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12532244 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.11540469 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10975074 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10539471 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10356969 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06021380 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04664807 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04158684 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.03481857 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01344515 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00960543 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00323758 |
| 57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.99290453 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99160807 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99032317 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.98864771 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97794519 |
| 62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.97529063 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97288199 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97141843 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.94879106 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94231283 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93987664 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92255814 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.91856044 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89379282 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.88864104 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87594780 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.86952123 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86303501 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.86017277 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85298210 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84633741 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.81869329 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.81618608 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80709061 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80189621 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.79392404 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79061201 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77701818 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77045549 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74712788 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74029776 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73377518 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.72942914 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71990473 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71900590 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71866116 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70965448 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70865375 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68985927 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67737553 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.67726619 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67501501 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66916675 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66695614 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66316570 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66230240 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66217646 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65716880 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.65661902 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65483102 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65385800 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65154870 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64825070 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64692009 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64646052 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64570392 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63996572 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62291938 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62233057 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61833298 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61779696 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61703284 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61208811 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60725658 |
| 121 | Renin secretion_Homo sapiens_hsa04924 | 0.60450255 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59023172 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58980189 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.58833086 |
| 125 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58655797 |
| 126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58641035 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58135988 |
| 128 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57911492 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57853424 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56958795 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56006658 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55351786 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53065974 |
| 134 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52776199 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52480656 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52421698 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.52143483 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.52099751 |
| 139 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51777052 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51405297 |
| 141 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50811182 |
| 142 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48775913 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48319812 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46105126 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43921609 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42753924 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42378574 |
| 148 | Melanogenesis_Homo sapiens_hsa04916 | 0.41801471 |
| 149 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41163625 |
| 150 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39869401 |
| 151 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36257918 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34972671 |
| 153 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33632650 |
| 154 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33304309 |
| 155 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31846523 |
| 156 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31351510 |
| 157 | Platelet activation_Homo sapiens_hsa04611 | 0.31265237 |
| 158 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29186279 |
| 159 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27966920 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27385971 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.25475067 |
| 162 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23960644 |
| 163 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23570885 |

